Article: article from journal or magazin.
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.
Transplantation Society International CMV Consensus Group
Kotton CN., Humar A., Caliendo AM., Lautenschlager I., Preiksaitis J., Kumar D., Abate D., Emery V., Khanna R., Lilleri D., Manuel O., Sester M., Humar A., Kotton CN., Blumberg E., Camargo LF., Gordon C., Huprikar S., Kamar N., Lattes R., Merville P., Mueller N., Paget G., Reischig T., Singh N., Snydman DR., Torre-Cisneros J., Westall G., Zamora M., Asberg A., Harrison J., Morris M., Munoz P., Rawlinson W., Chou S., Alain S., Baldanti F., Limaye AP., Lurain N., Danziger-Isakov L., Allen U., Green M., Herold BC., Michaels M.
Publication types: Consensus Development Conference ; Journal Article ; Practice GuidelinePublication Status: ppublish
Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.
Child, Cytomegalovirus Infections/drug therapy, Cytomegalovirus Infections/etiology, Drug Resistance, Viral, Humans, International Agencies, Monitoring, Immunologic, Organ Transplantation/adverse effects, Preoperative Care, Societies, Medical, Tissue Donors, Viral Vaccines/therapeutic use
Web of science
Last modification date